These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The effect of diuretic therapy on serum lipoproteins: an undesirable effect?]. Glück Z; Weidmann P; Mordasini R; Peheim E; Bachmann C; Keusch G; Riesen W Schweiz Med Wochenschr; 1979 Jan; 109(4):104-8. PubMed ID: 219471 [TBL] [Abstract][Full Text] [Related]
23. Antihypertensive effect of indapamide with special emphasis on renal prostaglandin production. LeBel M; Grose JH; Belleau LJ; Langlois S Curr Med Res Opin; 1983; 8 Suppl 3():81-6. PubMed ID: 6578003 [TBL] [Abstract][Full Text] [Related]
24. Effects of treatment with diuretics on serum lipoproteins. Weidmann P; Gerber A J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S260-8. PubMed ID: 6204152 [TBL] [Abstract][Full Text] [Related]
25. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245 [TBL] [Abstract][Full Text] [Related]
26. Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension. Ohta Y; Kamide K; Hanada H; Morimoto S; Nakahashi T; Takiuchi S; Ishimitsu T; Tsuchihashi T; Soma M; Tomohiro Katsuya T; Sugimoto K; Rakugi H; Oukura T; Higaki J; Matsuura H; Shinagawa T; Miwa Y; Sasaguri T; Igase M; Miki T; Takeda K; Higashiura K; Shimamoto K; Katabuchi R; Ueno M; Hosomi N; Kato J; Komai N; Kojima S; Sase K; Iwashima Y; Yoshihara F; Horio T; Nakamura S; Nakahama H; Miyata T; Kawano Y Hypertens Res; 2020 Mar; 43(3):220-226. PubMed ID: 31748705 [TBL] [Abstract][Full Text] [Related]
27. The diuretic indapamide increases bone mass and decreases bone resorption in spontaneously hypertensive rats supplemented with sodium. Lalande A; Roux C; Graulet AM; Schiavi P; De Vernejoul MC J Bone Miner Res; 1998 Sep; 13(9):1444-50. PubMed ID: 9738517 [TBL] [Abstract][Full Text] [Related]
28. Different blood pressure responses to diuretic treatment in normotensive subjects with and without a family history of hypertension. Ferrier C; Beretta-Piccoli C; Weidmann P; Bianchetti MG J Hypertens Suppl; 1983 Dec; 1(2):31-4. PubMed ID: 6599492 [TBL] [Abstract][Full Text] [Related]
29. Long-term effects of indapamide: final results of a two-year Italian multicenter study in systemic hypertension. Leonetti G; Rappelli A; Salvetti A; Scapellato L Am J Cardiol; 1990 May; 65(17):67H-71H. PubMed ID: 2184655 [TBL] [Abstract][Full Text] [Related]
30. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension. Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156 [TBL] [Abstract][Full Text] [Related]
31. The pharmacology and clinical pharmacology of indapamide. Campbell DB; Moore RA Postgrad Med J; 1981; 57 Suppl 2():7-17. PubMed ID: 7033951 [TBL] [Abstract][Full Text] [Related]
32. Effect of indapamide on serum and red cell cations, with and without magnesium supplementation, in subjects with mild hypertension. Taylor DR; Constable J; Sonnekus M; Milne FJ S Afr Med J; 1988 Sep; 74(6):273-6. PubMed ID: 3047887 [TBL] [Abstract][Full Text] [Related]
33. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels. Schaefer EJ; Lamon-Fava S; Cole T; Sprecher DL; Cilla DD; Balagtas CC; Rowan JP; Black DM Atherosclerosis; 1996 Nov; 127(1):113-22. PubMed ID: 9006811 [TBL] [Abstract][Full Text] [Related]
34. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes. Rizos E; Bairaktari E; Ganotakis E; Tsimihodimos V; Mikhailidis DP; Elisaf M J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):219-26. PubMed ID: 12490967 [TBL] [Abstract][Full Text] [Related]
35. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195 [TBL] [Abstract][Full Text] [Related]
36. Effects of indapamide, a thiazide-like diuretic, on structure of cerebral arterioles in hypertensive rats. Chillon JM; Baumbach GL Hypertension; 2004 May; 43(5):1092-7. PubMed ID: 15007039 [TBL] [Abstract][Full Text] [Related]
37. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731 [TBL] [Abstract][Full Text] [Related]
38. [Possibilities of using indices of vascular wall function as markers of negative metabolic effects of treatment with thiazide diuretics in patients with essential hypertension]. Semenkin AA Ter Arkh; 2007; 79(4):31-8. PubMed ID: 17564015 [TBL] [Abstract][Full Text] [Related]
39. Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents. Perry HM Am Heart J; 1983 Jul; 106(1 Pt 2):251-7. PubMed ID: 6869207 [TBL] [Abstract][Full Text] [Related]
40. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels. Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]